Skip to main content
. 2024 Jul 4;26(2):101055. doi: 10.1016/j.jocmr.2024.101055

Fig. 4.

Fig. 4

Utilization of linear or macrocyclic gadolinium-based contrast agents (GBCAs) by time (A) and 2015 GBCA designations by the American College of Radiology (B).